Inscripta announces strategic acquisition of Solana Biosciences

Inscripta announces strategic acquisition of Solana Biosciences

BOULDER -- Inscripta , a leading gene-editing technology company, today announced the strategic acquisition of Solana Biosciences, a life sciences company founded by Illumina (NASDAQ: ILMN)... Read More

Thursday September 6, 2018 0 comments Tags: Boulder, Inscripta, Solana Biosciences, Dr. Kevin Ness, Tom Rosso, John Stuelpnagel

Muse bio appoints John Stuelpnagel chairman of board of directors

Muse bio appoints John Stuelpnagel chairman of board of directors

BOULDER -- Muse bio , a privately-held company leading the development of next-generation genome engineering capabilities, announced Dr. John Stuelpnagel , co-founder, first CEO and former COO... Read More

Tuesday May 16, 2017 0 comments Tags: Boulder, Muse bio, John Stuelpnagel, Dr. Kevin Ness, ForgeCraft